Our Work

What we do

Our collaborative approach to research aims to:

  • Collaborative Research

    OBI is an active partner in the funding, fielding and dissemination of research. Championing high impact research programs, OBI accelerates innovation with the goal of better patient outcomes. Through the development and use of a state-of-the-art informatics platform designed to store, manage and analyze findings, OBI’s Brain-CODE is a “shared brain” for researchers in Ontario and beyond.

  • Commercial Innovation

    OBI partners with research and industry to co-ordinate commercialization and application of brain-related technologies. Through access to funding and support, OBI and its partners have created a track-record of success in nurturing and accelerating innovation.

    Programs like NERVE and NERD help de-risk investment in neurotechnologies bridging the funding gap between research and private capital to ensure validated brain-related technology.

  • Connected Care

    A focus on impact, means improving the lives of those affected by brain disorders. OBI creates new connections between patient groups, researchers, clinicians and other stakeholders, benefiting patients today and for generations to come.

    To ensure scale and efficiency OBI funds and manages five Integrated Discovery Programs – neurodegenerative disorders, neurodevelopmental disorders, cerebral palsy, depression and epilepsy. These programs provide evidence-based care back to patient groups, delivering real-world application and positive impact.

How we do it

Our goal is to improve the lives of Ontarians living with a brain disorder. We create seamless connections between research discovery, patient care and commercialization. We do this by connecting researchers, patients, companies, and policy makers.

Scroll through to learn about our major areas of focus.

Watch how OBI and its partners are bringing lab to life.

Play video

Our impact

Through partnerships and collaboration, OBI has transformed the province’s approach to brain health and produced direct impacts through its translational work.

One of our key proof points is in our ability to leverage funds: since our inception in 2010, we have taken an initial investment of $2 million dollars and converted it into a $600 million impact on brain healthcare to realize our vision of establishing the province as a world leader in brain research, commercialization, and care.